MENU
+Compare
GENFF
Stock ticker: OTC
AS OF
Jul 24 closing price
Price
$0.01
Change
-$0.00 (-0.00%)
Capitalization
5.08M

GENFF Genflow Biosciences Plc Forecast, Technical & Fundamental Analysis

Genflow Biosciences PLC is a preclinical biotechnology company focused on developing biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process, and reducing the incidence of age-related diseases and thereby increasing life span... Show more

GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GENFF with price predictions
Jul 25, 2025

GENFF's Stochastic Oscillator sits in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

GENFF broke above its upper Bollinger Band on July 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GENFF entered a downward trend on July 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 23, 2025. You may want to consider a long position or call options on GENFF as a result. In of 9 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GENFF just turned positive on July 21, 2025. Looking at past instances where GENFF's MACD turned positive, the stock continued to rise in of 6 cases over the following month. The odds of a continued upward trend are .

GENFF moved above its 50-day moving average on July 21, 2025 date and that indicates a change from a downward trend to an upward trend.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.259) is normal, around the industry mean (18.053). P/E Ratio (0.000) is within average values for comparable stocks, (59.920). GENFF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.580). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (280.104).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GENFF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GENFF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
6 Heddon Street
Phone
+44 2081425409
Employees
5
Web
https://www.genflowbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYNE1.460.12
+8.96%
VYNE Therapeutics
MFIC13.03N/A
N/A
MidCap Financial Investment Corp
GOLF82.17N/A
N/A
Acushnet Holdings Corp
FAST47.75-0.18
-0.38%
Fastenal Co
FDMT4.57-0.04
-0.87%
4D Molecular Therapeutics

GENFF and Stocks

Correlation & Price change

A.I.dvisor tells us that GENFF and TOVX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and TOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENFF
1D Price
Change %
GENFF100%
N/A
TOVX - GENFF
25%
Poorly correlated
+1.24%
VRCA - GENFF
23%
Poorly correlated
-5.57%
SGMT - GENFF
10%
Poorly correlated
+0.39%
OCS - GENFF
6%
Poorly correlated
+0.34%
APGE - GENFF
3%
Poorly correlated
-1.97%
More